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Objectives: The purpose of this study is to confirm that ANO1 correlates with occurrence and metastasis of 
OSCC. 
Study Design: Immunohistochemistry was used to detect the expression of ANO1 in 160 specimens of OSCC 
and normal tissues. Lentiviral silencing ANO1 was used in scc-25 cell line to study the cell migration and cell 
detachment.
Results: Immunohistochemical staining revealed that ANO1 was expressed in a large majority (132 out of 160, 
82.5%) of OSCC specimens and that the rate of ANO1 expression in OSCC was significantly higher than that of 
normal tissue (P<0.05); The rate of ANO1 expression was higher in metastatic tumors than in non-metastatic 
tumors, and the difference was significant (P<0.05). The results of cell migration assay showed that the percent-
age of cells through the membrane was 26.61 ±0.81 in assay group, and 54.26 ±3.74 in control group, respectively 
(t=-16.22,P<0.0001). The results of cell detachment assay showed that the percentage of cells detachment was 
37.42 ±0.90 in assay group, and 87.38 ±1.59 in control group, respectively (t=-62.34, P<0.0001). The results of 
wound healing assay showed the assay group had a reduced migration rate compared with the control group in 32 
h (F=1038.78, P<0.0001). Wound closure was no significantly different between the assay and control cells when 
DIDS was used in wound healing assay (F=4.61,P>0.05). 
Conclusions: Our study shows that abnormal expression of ANO1 correlated with the occurrence and metastasis 
of OSCC in clinical specimens and that silencing ANO1 greatly reduced migration ability of scc-25 cells. Calcium 
activated chloride channel activity of ANO1 promoted the cell migration. Thus, ANO1 could represent a new 
diagnostic biomarker and a potentially important therapeutic target of OSCC.
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Introduction
Oral squamous cell carcinoma (OSCC) encompasses at 
least 90% of all oral malignancies, and exhibits frequent 
local/regional invasion (1). The area is rich in vascular and 
lymphatic vessels, there is a high propensity for oral cancer 
to metastasis to the other sites of body. Despite multiple 
modalities of treatment, such as surgery, radiation, and 
chemotherapy, oral cancer continued to have one of the 
lowest 5-year survival rates and thus has been an impor-
tant research topic for surgeons (2). Improvement in patient 
survival requires better understanding of tumor occur-
rence and metastasis, and needs an effective biomarker for 
the occurrence and metastasis of oral cancer, so that these 
aggressive tumors can be detected at the earlier stages in 
the disease development process and targeted therapeutic 
interventions for this type of cancer can be developed.
According to the results of other studies (3,4), amplifi-
cations, abnormal expression and activation of chloride 
channels have been known to correlate with tumor oc-
currence and metastasis in several types of cancer cells. 
For example, glioma cells have strong invasiveness. 
Chloride channels’ activation was detected in the deve-
lopment and progression process of glioma cells. Recent 
studies have shown that the upregulation of chloride 
channels in glioma cell membrane enhanced the ability 
of its migration (5,6). Chloride channels were activated 
when glioma cells migrated. The blockers of chloride 
channels could prevent the migration of glioma cells. 
Thus, the chloride channels also play an important role 
in the process of cell migration (7). 
Anoctamin-1 (ANO1), also known as oral cancer over-
expressed 2 (ORAOV2), is one of the chloride channel 
proteins in humans and is encoded by the ANO1 gene 
located on 11q13 (8), a chromosomal region that is fre-
quently amplified in different types of human carcino-
mas (9,10). ANO1 has recently been identified as a Ca2+ 
-activated chloride channel (11-13). There is a well rec-
ognized link between expression of chloride channels 
and cancer occurrence and metastasis (14,15). However, 
a detailed analysis of ANO1 expression in oral squamous 
cell carcinoma (OSCC) and its functions is missing. It is 
thus still unclear how ANO1 contributes to malignancy 
in OSCC. The purpose of this study is to determine 
whether abnormal expression of ANO1 correlates with 
occurrence and metastasis of OSCC. Thus, we analyzed 
the expression of ANO1 in OSCC samples and defined 
its functions in human oral cancer cell line. 
Material and Methods
-Patients and samples
Histological studies were made of 160 patients with 
primary OSCC at the Department of Oral and Maxil-
lofacial Surgery, the First Affiliated Hospital of Chong-
qing Medical University, between January of 2000 and 
December of 2011. None of the patients had been treated 
previously with chemotherapy or radiotherapy. All the 
participated patients were informed and agreed with this 
study. They were staged according to the UICC TNM 
Classification of Malignant Tumors (16). A fragment 
of primary tumour and a fragment of normal mucosal 
close to tumour were removed, fixed in 6% buffered 
formaldehyde and embedded in paraffin for immuno-
histochemical analysis. General characteristics of the 
patients involved in this study are presented in table 1.
 ANO1   
Variable Number of 
cases 
Negative Positive Statistical P  value 
    value  
differentiation      
I 56 9 47 0.2760 0.8740 
II 74 14 60   
III 30 5 25   
lymph node      
N0 44 16 28 6.2773 0.012* 
N1,2 116 12 104*   
clinical stage      
II 56 18 38 5.9743 0.0145* 
III, IV 104 10 94*   
ages      
30-59 140 26 114 0.3168 0.5735 
60- 20 2 18   
sex      
male 102 18 84 0.0001 0.9940 
female 58 10 48   
?
Table 1. The relative of the expression of ANO1 and pathogenic and clinic parameters of OSCC patients.
Chi-square test,*P<0.05.
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-Immunohistochemical Analysis
Paraffin-embedded specimens were sectioned and pre-
treated in a microwave for 5 minutes for antigen retriev-
al. Incubation with primary antibody (rabbit polyclonal 
anti-ANO1 1/500 Sigma) was carried out at 4°C over-
night. Peroxidase-labeled anti-rabbit immunoglobulin 
was used as secondary antibody. Streptavidia/Pemxida 
kit (ZYMED,USA) was used for revelation. The appear-
ance of brown staining in the cell was considered posi-
tive for this protein.
-Cell culture
Tongue cancer accounts for a majority of the cases of 
oral and maxillofacial malignancies, so tongue cancer 
cell line (scc-25) was used in this study. Human cell 
line of scc-25 (Center Laboratory of Chongqing Medi-
cal University) were grown in modified Eagle’s medium 
(Sigma, USA), supplemented with 10% fetal calf serum, 
1 mM Sodium pyruvate, 40µg/ml gentamycin. (Gibco, 
USA) at a temperature of 37°C in an environment con-
taining 5% CO2.
Lentiviral-mediated siRNA targeted against ANO1
Three shRNA sequences targeting ANO1 (GeneBank ac-
cession NR_030691) and a negative sequence for control 
were designed and approved by BLAST software. The four 
sequences were synthesized as follows: negative control 
shRNA, 5’-CATGGAGTGGCACGTAGGT-3’; ANO1-
shRNA 1: 5’-TTACGTGGCGTTCTTCAAA-3’; ANO1-
shRNA 2: 5’-GCACGATTGTCTATGAGAT-3’; ANO1-
shRNA 3:  5’-GAATCATTGTCTTCCTGTATT-3’. These 
shRNAs were cloned into pTY linkers (Lentiviral vectors). 
shRNA lentiviral vector was transiently transfected into 
HEK-293T cells via calcium phosphate-mediated transient 
transfection. Lentivirus was transfected into scc-25 cells.
-Reverse Transcription-Polymerase Chain Reaction 
(RT-PCR) 
Total RNA was extracted with GeneElute mammalian 
total RNA miniprep kit (Sigma), verified by agarose gel 
electrophoresis for integrity, reverse transcribed with Su-
perscript II (RTase SC, Life Technologies) and oligodT 
primer (Sigma), and amplified by PCR using a LightCy-
cler and LC Fast start DNA master SYBR green I kit (Ro-
che Diagnostics). The primers were designed by primer3 
software(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_
www.cgi). The primer sequences for AN01 were:ANO1 
forward primer:5’-CTCCTGGACGAGGTGGTATGG-3’ 
and reverse primer: 5’-GAACGCCACGTAAAAGAT-
GG-3’; The primers for the ubiquitous gene ribosomal 
protein P0 (RPLP0) were: forward primer: 5’-GAAG-
GCTGTGGTGCTGATGG-3’ and reverse primer:5’-
CCGGATATGAGGCAGCAGTT-3’. The specificity of 
the PRC amplified products was verified by agarose gel 
electrophoresis and expression levels of AN01 were nor-
malized with RPLP0.
-Western blot analysis
Cells were lysed in 50ul lysis buffer(1 mM dithio-
threitol, 0.125 mM EDTA, 5% glycerol, 1 mM 
phenylmethylsulfonylﬂuoride, 1 lg/ml leupeptin, 1 lg/
mlpepstatin, 1 lg/ml aprotinin, 1% Triton X-100 in 12.5 
mMTris–HCl buffer, pH 7.0) , and heat denatured. Proteins 
were separated by 10% sodium dodecyl sulphate-polyacr-
ylamide gel electrophoresis (SDS–PAGE) and transferred 
to nitrocellulose membrane, blocked by 5% dry milk, and 
the membranes were incubated with anti-ANO1 (1/1000) 
and anti-TBP (1/2000,Sigma,USA) antibodies. Following 
incubation with horseradish peroxidase-conjugated sec-
ondary antibody and the membranes were developed with 
the enhanced chemiluminescence kit (Pierce). 
-Cell Migration Assay
Transwell chambers with 6.5 mm polyvinyl/pyrrolidone-
free polycarbonate filters of 8 μm pore size were used. 
Cells (4×105 mL−1) were suspended in 100 μL of serum-
free medium in the upper transwell chamber; 10% FCS-
containing medium was placed in the lower chamber. Af-
ter 4 h of incubation at 37°C,cells on the upper surface of 
the filter were completely wiped away with a cotton swab, 
and the lower surface of the filter was fixed in methanol, 
stained with Giemsa and counted under a microscope.
-Cell detachment assay  
To measure detachment, cells were plated at a density of 
4×104 mL−1 in 500μL of medium in 24-well plates (In-
tegrated BioDiagnostics, Germany) and incubated for 24 
h at 37°C. A stock trypsin-EDTA solution (0.05%) was 
diluted to 50% of the stock concentration. The cells were 
washed with phosphate-buffered saline (PBS) and incu-
bated in diluted trypsin for 10 min at 37°C. All detached 
cells were collected following one wash with PBS. The 
detached cells and remaining cells were counted.
-In vitro wound healing assay
Cells were plated in duplicate in 24-well plates, grown 
to conﬂuence, and scraped with sterile 200μL dispos-
able plastic pipette tips and washed with PBS. Cells 
were incubated with serum free medium containing 5 
μM Aphidicolin (Sigma) to inhibit cell proliferation. 
The wound healing procedure was observed by micros-
copy, and images were collected. The distance between 
the wound edges was measured using Adobe Photoshop 
CS2. Wound closure was presented as percentage of re-
duction of the freshly wounded area. To study the ef-
fects of 4-4′-Diisothiocyanatostilbene-2,2′-disulfonic 
acid disodium salt (DIDS), cells were incubated with 
100μM DIDS ( dissolved in DMSO 0.1%) and photo-
graphed after 0, 8, 24 and 32 h.
-Statistical analysis
Statistical significance was assessed using Chi-square 
test, Student’s t-test and ANOVA. A P value < 0.05 was 
considered to be statistical significance.
Results
-Expression of ANO1 in specimens of OSCC 
For immunohistochemical analysis, staining in all spec-
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imens was restricted to the tumor cells, with no stain-
ing of the stroma. No staining was detected in normal 
mucosal. Protein expression of ANO1 was detected in 
132 (82.5%) of 160 cancer tissues. The rate of ANO1 
expression was higher in metastatic tumors than in 
non-metastatic tumors, and the difference was statisti-
cally significant (Chi-square test, P<0.05). The rate of 
ANO1 expression increased in accordance to clinical 
stage(P<0.05). No significant differences between the 
rate of ANO1 expression and differentiation, sex and 
age were observed (P>0.05) (Fig. 1, Table1). 
-Silencing efficacy of ANO1 with shRNA lentivirus
As assay group, the stable silencing of ANO1 scc-25 cell 
line was successfully built with ANO1- shRNA1 lenti-
virus. The control group of scc-25 cell line was success-
fully built with negative control shRNA lentivirus. The 
silencing efficacy of ANO1 shRNA lentivirus at mRNA 
and protein levels in scc-25 cells was determined by RT-
PCR and Western blot, respectively. The results of RT-
PCR showed that the expression levels of ANO1 mRNA 
were 0.14±0.01 in assay group and 0.32±0.02 in control 
group, respectively (Fig. 1). The ANO1 mRNA level in 
shRNA1 lentivirus-cells was reduced to 43.75% (a 2.29 
fold reduction) of that in the control group. The diffe-
rence in ANO1 mRNA levels between the assay and 
control group was statistically significant (Student’s t-
test, t=-24.55, P<0.0001); and Western blot revealed that 
the protein expression levels of ANO1 were 0.22±0.08 
in assay group, and 1.16±0.09 in control group, respec-
tively (Fig. 1). The protein level of ANO1 in the assayed 
group was reduced to 18.97% (a 5.27 fold reduction) of 
that of the control group. The difference in ANO1 pro-
tein levels between the assay and control group was sta-
tistically significant (t=-19.66, P<0.0001). The results of 
both RT-PCR and Western blot demonstrated that lenti-
viral vectors were effective for ANO1 silencing.
-Effects of silencing ANO1 on cell migration and de-
tachment 
The effect of silencing ANO1 on cell migration was 
exa-mined with Transwell chambers assay. After incu-
bation for 4 h, the percentage of cells through the mem-
brane was 26.61 ±0.81 in assay group, and 54.26 ±3.74 
in control group, respectively (t=-16.22, P<0.0001) (Fig. 
2) and the cell migration rate in assay group was re-
duced by 2.04 fold of that in the control group. The re-
sults of this experiment suggested that silencing ANO1 
expression reduced migration ability of scc-25 cells. To 
examine the effect of silencing ANO1 on cell detach-
ment, cell detachment assay was performed. The results 
showed that the percentage of cells detachment was 
37.42 ±0.90 in assay group and 87.38 ±1.59 in control 
group, respectively (t=-62.34, P<0.0001) (Fig. 2) and 
the cell detachment rate in assay group was reduced by 
2.34 fold of that in the control group. To further investi-
gate the effect of silencing ANO1 on cell migration, in 
vitro wound healing assay was performed. The results 
showed that the cells transfected with ANO1- shRNA1 
lentivirus had an extended wound closure time as com-
pared with that in the control group in 32 h (ANOVA, 
F=1038.78, P<0.0001) (Fig. 2). Silencing ANO1 in hu-
Fig. 1. Expression of ANO1 in clinical specimens and the scc-25 cells. A: ANO1 is negative in oral normol tissure by immunohistochem-
ical staining SP×200; B: ANO1 is positive in oral cancer tissure by immunohistochemical staining SP×200; C: ANO1 is negative in oral 
cancer tissure by immunohistochemical staining SP×200; D: The RT- PCR analysis of ANO1 mRNA levels in scc-25 cells after infection 
with lentivirus,the expression levels of ANO1 mRNA were (0.14±0.01) in assay group,(0.32±0.02) in control group, (Student’s t-test, t=-24.55, 
P<0.0001); E: The Western blots analysis of ANO1 protein expression in scc-25 cells after infection with lentivirus,the protein expression levels 
of ANO1 were(0.22±0.08) in assay group,(1.16±0.09)in control group , (t=-19.66, P<0.0001).
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man scc-25 cells led to reduced cell migration and de-
tachment to a greater extent than that in control cells, 
implying that ANO1 knockdown may preferentially in-
hibit metastasis of human scc-25 cells.
-DIDS decrease scc-25 cell migration in control cells
To investigate whether calcium activated chloride 
channel activity of ANO1 promotes the cell migration, 
DIDS, an inhibitor of anion exchange channel, was used 
in in vitro wound healing assay. The results showed that 
DIDS delayed wound closure in the control cells, since 
the expression of ANO1 was not knockdown. The lack 
of an effect on assay cells is expected because of si-
lencing ANO1. So wound closure was no significantly 
different between the assay and control cells (F=4.61, 
P>0.05) (Fig. 3), which showed that ANO1 channel ac-
tivity participated in the scc-25 cell migration.
Discussion
ANO1 belongs to a novel family of membrane chloride 
proteins with cytosolic amino- and carboxyl termini 
facing the cytoplasm (17). ANO1 has been suggested 
to drive 11q13 amplification by providing growth or 
metastatic advantage to tumours. Several studies have 
indicated that ANO1 may be of clinical value as a diag-
nostic and prognostic biomarker and therapeutic target 
of tumours (18,19). 
Our study indicated that ANO1 could be a marker of 
occurrence and metastasis in OSCC. 
In this study, we reported, for the first time, a relatively 
detailed analysis of ANO1 expression in OSCC. First, 
we performed the analysis of the expression of ANO1 
in 160 patient samples of primary OSCC with immuno-
histochemical assay. We have shown that ANO1 expres-
sion was found in a large majority (132 out 160, 82.5%) 
of oral cancer tissue, but not in normal tissue and its 
expression level was higher in metastatic tumors than in 
non-metastatic tumors. Furthermore, we also observed 
that ANO1 expression strongly correlated with the in-
creasing clinical stage of OSCC patients. These results 
are in accordance with those reported in other studies 
Fig. 2. Effects of silencing ANO1 on cell migration and detachment. A: Transwell chambers assay was used to examine the effect of silenc-
ing ANO1 on cell migration. After incubation for 4 h, the percentage of cells through the membrane was (26.61 ±0.81) in assay group, (54.26 
±3.74) in control group, (t=-16.22, P<0.0001); B: Cell detachment assay was performed to examine the effect of silencing ANO1 on cell detach-
ment. The results showed that the percentage of cells detachment was (37.42 ±0.90) in assay group, (87.38 ±1.59) in control group, (t=-62.34, 
P<0.0001); C and D: In vitro wound healing assay was performed to further investigate the effect of silencing ANO1 on cell migration. The 
results showed that the cells transfected with ANO1- shRNA1 lentivirus had a extended wound closure time compared with the control group 
in 32 h (ANOVA, F=1038.78, P<0.0001).
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Fig. 3. DIDS decreases scc-25 cell migration in control cells. A,B: 
To investigate whether calcium activated chloride channel activity 
of ANO1 promote the cell migration, the inhibitor (DIDS) was used 
in vitro wound healing assay. The results showed that wound closure 
were no signifcantly different between the assay and control cells 
(F=4.61, P>0.05)
(18,20). A correlation between the expression of ANO1 
and various types of cancers and diseases including 
urinary bladder cancer, breast cancer, head and neck 
squamous cell carcinoma and cystic fibrosis has been 
reported (8,20,21). ANO1 is rarely expressed in corre-
sponding normal tissues. Our results imply that ANO1 
correlates with the occurrence (22) and the metastasis 
of OSCC, and that ANO1 could act as an independent 
marker of occurrence and metastasis for OSCC. 
To explore the cellular function of ANO1, we conducted 
a series of experiments with scc-25 cell line. First, we 
knocked down ANO1 expression in scc-25 cell line with 
shRNA lentivirus and examined the effects knocking 
down ANO1 expression on cell migration and detach-
ment with cell migration assay, detachment assay and 
in vitro wound healing assay with silencing ANO1 scc-
25 cell line. We detected significantly reduced cellular 
migration and detachment in scc-25 cell caused by si-
lencing ANO1. Detachment and migration of cells are 
essential steps for metastasis of tumor cells, to regional 
and distant sites which threatens patients’ lives. By re-
ducing metastasis of cancer cells could be one of the 
effective ways to save many patients lives from cancers. 
Our study showed that silencing ANO1 might be useful 
to prevent tumor metastasis at least in OSCC.
ANO1 is a Ca2+-activated chloride channel (11-13). The 
functions of Ca2+-activated chloride channel include 
governing cellular ion ﬂuxes and regulating cell volume 
(23). There is substantial evidence that cell migration is 
facilitated by the function of chloride channels (3,6,24). 
The process of cell migration comprises cell swelling 
at the leading edge and subsequent cell shrinkage at 
the rear part of the cell (25). The chloride channels are 
involved in the changes in cell migration (26). When 
cells migrate, they need to change their volume and also 
require the involvement of cytoskeleton. Thus, being a 
Ca2+-activated chloride, ANO1 might be involved in 
the control of cell migration by regulating the cell vol-
ume. Indeed, Ruiz et al. found that ANO1 regulated cell 
volume and causes cell migration (20). Perez-Cornejo 
found that ANO1 might play a role in organization of 
the actin cytoskeleton (27). Therefore, it is likely that 
ANO1 accelerates the migration of cancer cells by regu-
lating the coordinated changes in cell volume and or-
ganization of cytoskeleton. 
It is quite reasonable that if ANO1 is involved in cell 
migration, then inhibition of its activity should block or 
reduce cell migration. Indeed, it has been reported that 
blocking chloride channel inhibits migration of nasopha-
ryngeal carcinoma cells (28), and that inhibition of ANO1 
suppressed the migration of prostate carcinoma cells in 
vitro (18). Thus, we used DIDS, an inhibitor of anion ex-
change channel, to examine its effects on wound closure 
using in vitro wound healing assay. Our results showed 
that DIDS delayed wound closure in scc-25 cell line. The 
results also support the concept of chloride channel being 
an essential factor that determines abilities of the cells 
to migrate and to metastasize (29,30). We reasoned that 
chloride channel activity of ANO1 takes part in cell mi-
gration which facilitates the emergence of metastasis in 
OSCC and in other cancers as well.
In addition to its role in regulation of cell migration and 
metastasis, ANO1 may be also involved in other cel-
lular processes. Duvvuri et al. found that ANO1 could 
improve cancer cell proliferation and increased activa-
tion of extracellular signal-regulated kinase (ERK) at 
the same time and silencing ERK could abrogate the 
growth effect of ANO1 (22). Also, ANO1 induced pro-
liferation by mitogen-activated protein kinase (MAPK) 
activation (22).
Taking these lines of evidence together, it is reasonable 
to conclude that abnormal expression and activation 
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of ANO1 correlates with the occurrence, progression 
and metastasis of cancer and that ANO1 could be an 
important target of therapeutic drugs. However, since 
the role of ANO1 in cell migration and detachment is 
determined in vitro studies, whether or not this find-
ing can be transferable to the in vivo situation requires 
to be further verified. Thus, further experimental work 
will be required to define the precise roles of ANO1 on 
OSCC metastasis in vivo for the development of small-
molecule inhibitors against ANO1.
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